Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2- Recovered Dialysis Patients.
Philippe AttiasImane AzzaouiKhalil El KarouiAndréa de La SelleAurélien SokalPascal ChappertPhilippe GrimbertIgnacio FernandezMagali Bouvier-AliasChloé SamsonDjamal DahmanePhilippe RieuPatrice NizardSlim FouratiHamza SakhiMatthieu Mahévasnull nullPublished in: Clinical journal of the American Society of Nephrology : CJASN (2022)
COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells (MEMO-COV2), NCT04402892.
Keyphrases
- sars cov
- end stage renal disease
- respiratory syndrome coronavirus
- chronic kidney disease
- immune response
- peritoneal dialysis
- ejection fraction
- newly diagnosed
- coronavirus disease
- prognostic factors
- cell cycle arrest
- toll like receptor
- working memory
- patient reported outcomes
- inflammatory response
- patient reported
- endoplasmic reticulum stress